Glimepiride
Product Images NDC 42549-499

6 FDA label images from Stat Rx Usa Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 42549-499). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Glimepiride 2 mg Label 42549)

Label Image (Glimepiride 2 mg Label  42549)
The packaging label for Glimepiride 2 mg tablets, distributed by STAT Rx USA LLC. The label indicates the product contains 30 tablets and is a generic for Amaryl. It includes NDC 42549-499-30 and states each tablet contains 2 mg of Glimepiride USP. Manufactured by Perrigo in Allegan, MI, with lot number 693949 and discard date 04/15. Additional warnings and storage instructions are partially visible.*
FDA Label Image

Adv Reactions Image (Glimepiride 2 mg Adv Reactions Image)

Adv Reactions Image (Glimepiride 2 mg Adv Reactions Image)
A data table comparing adverse events occurring in more than 1% of Glimepiride patients versus placebo. The table lists total treated, dizziness, asthenia, headache, and nausea with corresponding patient numbers and percentages for both Glimepiride and placebo groups.*
FDA Label Image

Clinical Pharma Image (Glimepiride 2 mg Clinical Pharma Image)

Clinical Pharma Image (Glimepiride 2 mg Clinical Pharma Image)
A data table comparing pharmacokinetic parameters including Cmax, Tmax, clearance (CL/f), volume of distribution (Vd/f), and half-life (T1/2) among volunteers and patients with type 2 diabetes after single and multiple doses of glimepiride. The table presents mean values with standard deviations and sample sizes for each parameter and dose regimen.*
FDA Label Image

Precautions Image 1 (Glimepiride 2 mg Precautions Image 1)

Precautions Image 1 (Glimepiride 2 mg Precautions Image 1)
A table comparing HbA1c percentage changes between naïve and previously treated patients using Metformin or Glimepiride. It shows baseline means, changes from baseline, and adjusted treatment differences with 95% confidence intervals for each group.*
FDA Label Image

Precautions Image 2 (Glimepiride 2 mg Precautions Image 2)

Precautions Image 2 (Glimepiride 2 mg Precautions Image 2)
A data table comparing weight (kg) changes between Metformin and Glimepiride treatment groups. It includes baseline mean weights, mean change from baseline, and adjusted treatment differences with 95% confidence intervals, alongside footnotes clarifying the study population and statistical adjustments.*
FDA Label Image

Structure Image (Glimepiride 2 mg Structure Image)

Structure Image (Glimepiride 2 mg Structure Image)
Chemical structure diagram of the active ingredient for GLIMEPIRIDE, showing its molecular connectivity and functional groups as part of the product labeling from STAT Rx USA LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.